Appendix A: Key to Acronyms
Updated
Reviewed
Study and Trial Names
| Acronym/Abbreviation | Full Name |
|---|---|
| ANRS | ANRS French Perinatal Cohort |
| BAN | Breastfeeding, Antiretrovirals, and Nutrition |
| DolPHIN 2 | Dolutegravir in Pregnant HIV Women and Their Neonates |
| EPPICC | European Pregnancy Paediatric HIV Cohort Collaboration |
| EUROCAT | European Surveillance of Congenital Anomalies and Twins |
| HPTN | HIV Prevention Trials Network |
| IMPAACT | International Maternal Pediatric Adolescent AIDS Clinical Trials |
| MOTIVATE | Mother–Infant Visit Adherence and Treatment Engagement |
| PACTG | Pediatric AIDS Clinical Trials Group |
| PANNA | Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women |
| PARTNER | Partners of People on ART-A New Evaluation of the Risks |
| PEPI-Malawi | Post-Exposure Prophylaxis of Infants |
| PHACS | Pediatric HIV/AIDS Cohort Study |
| PROMISE | Promoting Maternal and Infant Survival Everywhere |
| SMARTT | Surveillance and Monitoring for ART Toxicities |
| START | Strategic Timing of AntiRetroviral Treatment |
| SWEN | Six-Week Extended-Dose Nevirapine |
| VESTED | Virologic Efficacy and Safety of ART Combinations with TAF/TDF, EFV, and DTG |
Download Guidelines
- Section Only PDF (38.1 KB)
- Full Guideline PDF (5.56 MB)
- Recommendations Only PDF (410.31 KB)
- Tables Only PDF (967.23 KB)